VIMTA LABS
Back to Income Statement
|
VIMTA LABS Last 5 Year Revenue History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Net Sales | ₹318 Cr | ₹318 Cr | ₹278 Cr | ₹211 Cr | ₹181 Cr |
What is the latest Revenue of VIMTA LABS ?
| Year | Revenue |
|---|---|
| Mar2024 | ₹318 Cr |
| Mar2023 | ₹318 Cr |
| Mar2022 | ₹278 Cr |
| Mar2021 | ₹211 Cr |
| Mar2020 | ₹181 Cr |
How is Revenue of VIMTA LABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2024 | ₹318 Cr | 0.02 | |
| Mar2023 | ₹318 Cr | 14.34 | |
| Mar2022 | ₹278 Cr | 32.09 | |
| Mar2021 | ₹211 Cr | 16.58 | |
| Mar2020 | ₹181 Cr | - | |
Compare Revenue of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,971.9 Cr | -3.6% | -12.6% | 144% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,248.0 Cr | 1.8% | 2.7% | -11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,177.0 Cr | -0.6% | 7.7% | 9.4% | Stock Analytics | |
| CIPLA | ₹132,898.0 Cr | 4.9% | 6.7% | 7.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹122,428.0 Cr | 2.4% | -1% | 4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,818.0 Cr | 3.2% | -1.7% | -4.5% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -3.6% |
-12.6% |
144% |
| SENSEX | 2.4% |
2.3% |
4.4% |
You may also like the below Video Courses